Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021
- PMID: 38844846
- PMCID: PMC11157953
- DOI: 10.1186/s10194-024-01798-z
Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021
Abstract
Background: Migraine, a neurological disorder with a significant female predilection, is the leading cause of disability-adjusted life years (DALYs) in women of childbearing age (WCBA). There is currently a lack of comprehensive literature analysis on the overall global burden and changing trends of migraines in WCBA.
Methods: This study extracted three main indicators, including prevalence, incidence, and DALYs, related to migraine in WCBA from the Global Burden of Disease(GBD) database from 1990 to 2021. Our study presented point estimates with 95% uncertainty intervals (UIs). It evaluated the changing trends in the burden of migraine in WCBA using the estimated annual percentage change (EAPC) and percentage change.
Results: In 2021, the global prevalence, incidence, and DALYs cases of migraine among WCBA were 493.94 million, 33.33 million, and 18.25 million, respectively, with percentage changes of 48%, 43%, and 47% compared to 1990. Over the past 32 years, global prevalence rates and DALYs rates globally have increased, with an EAPC of 0.03 (95% UI: 0.02 to 0.05) and 0.04 (95% UI: 0.03 to 0.05), while incidence rates have decreased with an EAPC of -0.07 (95% UI: -0.08 to -0.05). Among the 5 Socio-Demographic Index (SDI) regions, in 2021, the middle SDI region recorded the highest cases of prevalence, incidence, and DALYs of migraine among WCBA, estimated at 157.1 million, 10.56 million, and 5.81 million, respectively, approximately one-third of the global total. In terms of age, in 2021, the global incidence cases for the age group 15-19 years were 5942.5 thousand, with an incidence rate per 100,000 population of 1957.02, the highest among all age groups. The total number of migraine cases and incidence rate among WCBA show an increasing trend with age, particularly in the 45-49 age group.
Conclusions: Overall, the burden of migraine among WCBA has significantly increased globally over the past 32 years, particularly within the middle SDI and the 45-49 age group. Research findings emphasize the importance of customized interventions aimed at addressing the issue of migraines in WCBA, thus contributing to the attainment of Sustainable Development Goal 3 set by the World Health Organization.
Keywords: DALYs; Disease burden; GBD 2021; Migraine; WCBA.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
A comprehensive analysis of trends and inequalities in rheumatoid arthritis burden among women of childbearing age: insights from the Global Burden of Disease Study 2021.Clin Exp Rheumatol. 2025 Jul;43(7):1321-1331. doi: 10.55563/clinexprheumatol/r9rruc. Epub 2025 May 8. Clin Exp Rheumatol. 2025. PMID: 40371555
-
Trends and predictions of the global burden of ischemic heart disease in women of childbearing age attribute to high body mass index and hypertension,1990-2021: a systematic analysis for the Global Burden of Disease Study.BMC Cardiovasc Disord. 2025 May 9;25(1):360. doi: 10.1186/s12872-025-04741-5. BMC Cardiovasc Disord. 2025. PMID: 40346517 Free PMC article.
-
Global, regional, and national burden and trends of migraine among youths and young adults aged 15-39 years from 1990 to 2021: findings from the global burden of disease study 2021.J Headache Pain. 2024 Aug 12;25(1):131. doi: 10.1186/s10194-024-01832-0. J Headache Pain. 2024. PMID: 39134934 Free PMC article.
-
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.JAMA Oncol. 2022 Mar 1;8(3):420-444. doi: 10.1001/jamaoncol.2021.6987. JAMA Oncol. 2022. PMID: 34967848 Free PMC article.
-
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.JAMA Neurol. 2021 Feb 1;78(2):165-176. doi: 10.1001/jamaneurol.2020.4152. JAMA Neurol. 2021. PMID: 33136137 Free PMC article.
Cited by
-
Global, regional, and national burden and trends of kidney cancer associated with high BMI from 1990 to 2021: Findings from the Global Burden of Disease Study 2021.PLoS One. 2025 Mar 24;20(3):e0320185. doi: 10.1371/journal.pone.0320185. eCollection 2025. PLoS One. 2025. PMID: 40127090 Free PMC article.
-
Chronification of migraine sensitizes to CGRP in male and female mice.Cephalalgia. 2025 Feb;45(2):3331024251317446. doi: 10.1177/03331024251317446. Cephalalgia. 2025. PMID: 39945018 Free PMC article.
-
Global health burden and inequality patterns of occupational noise exposure from 1990 to 2019.Sci Rep. 2025 Jul 10;15(1):24844. doi: 10.1038/s41598-025-09575-x. Sci Rep. 2025. PMID: 40640340 Free PMC article.
-
Health inequality and the global burden of mesothelioma: insights from the global burden of disease study 2021.BMC Cancer. 2025 Jul 16;25(1):1179. doi: 10.1186/s12885-025-14590-2. BMC Cancer. 2025. PMID: 40670971 Free PMC article.
-
Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders.CNS Drugs. 2025 Aug 7. doi: 10.1007/s40263-025-01213-4. Online ahead of print. CNS Drugs. 2025. PMID: 40775197 Review.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous